L'Oreal

Annual General Meeting of 29 April 2025

30 Apr 2025

Annual General Meeting of 29 April 2025 Renewal of the term of office as Directors of Mr. Nicolas Hieronimus, Mr. Paul Bulcke, and Mr. Alexandre Ricard Appointment of Téthys, Ms. Isabelle Seillier, an

First quarter 2025 sales

17 Apr 2025

Solid in the Storm Like-for-like growth of +3.5% Sales: 11.73 billion euros, +4.4% reported and +3.5% like-for-like[1]. Sales growth benefited from the phasing related to the 2024 and 2025 IT transfor

Share buyback program

02 Apr 2025

L'Oréal announced to have today entered into a mandate with an investment services provider for the purchase of its own shares, under the authorisation approved by the Annual General Meeting of 2

L’Oréal successfully prices a 1.25 billion euro dual tranche bond

04 Mar 2025

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA L’Oréal successfully prices a 1.25 billion euro dual tranche bond Clichy,

L’Oréal Groupe is delighted to announce a long-term, exclusive beauty partnership with JACQUEMUS

07 Feb 2025

L'ORÉAL GROUPE SIGNS AN EXCLUSIVE AGREEMENT WITH JACQUEMUS L’Oréal Groupe is delighted to announce a long-term, exclusive beauty partnership with JACQUEMUS, further solidified by a minority inves

2024 Annual Results

07 Feb 2025

Solid +5.1% Growth in a Challenging Context Record Results, Reaching 20% Operating Margin Sales: 43.48 billion euros, +5.6% reported and +5.1% like-for-like[1].

Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal

03 Feb 2025

L’Oréal announces today that it has agreed to sell approximately 29.6 million of Sanofi shares to Sanofi for €101.5 per share, for a total consideration of €3 billion. Upon completion of the transacti

Sales at 30 September 2024

29 Nov 2024

Solid +6% growth despite turbulences Sales: 32.40 billion euros, +6.0% like-for-like[1], +6.0% reported. Growth in all Divisions with L’Oréal Luxe accelerating a third consecutive quarter, Professiona

L’Oréal Groupe acquires a 10% stake in Galderma, the pure-play dermatology leader and one of the world’s largest players in injectable aesthetics

29 Nov 2024

Inside information L’ORÉAL GROUPE ACQUIRES A 10% STAKE IN GALDERMA, THE PURE-PLAY DERMATOLOGY LEADER AND ONE OF THE WORLD’S LARGEST PLAYERS IN INJECTABLE AESTHETICS.

Availability of the 2024 half-year Financial report

29 Nov 2024

L’Oréal announces that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2024. The 2024 Half-Year Financial Report ca

View details about the software product Informachine News Trackers